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Objective  To investigate the short-term effects and advantages of sono-guided capsular distension, compared 
with fl  uoroscopically guided capsular distension in adhesive capsulitis of shoulder.
Method  In this prospective, randomized, and controlled trial, 23 patients (group A) were given an intra-articular 
injection of a mixture of 0.5% lidocaine (9 ml), contrast dye (10 ml), and triamcinolone (20 mg); they received 
the injection once every 2 weeks, for a total of 6 weeks, under sono-guidance. Twenty-five patients (group B) 
were treated similarly, under fl  uoroscopic guidance. Instructions for the self-exercise program were given to all 
subjects, without physiotherapy and medication. Eff  ects were then assessed using a visual numeric scale (VNS), 
and the shoulder pain and disability index (SPADI), as well as a range of shoulder motion examinations which 
took place at the beginning of the study and 2 and 6 weeks after the last injection. Incremental cost-eff  ective ratio 
(ICER), eff  ectiveness, preference, and procedure duration were evaluated 6 weeks post-injection.
Results  The VNS, SPADI, and shoulder motion range improved 2 weeks after the last injection and continued to 
improve until 6 weeks, in both groups. However, no statistical differences in changes of VNS, SPADI, ROM, and 
eff  ectiveness were found between these groups. Patients preferred sono-guided capsular distension to fl  uoroscopically 
guided capsular distension due to diff  erences in radiation hazards and positional convenience. Procedure time was 
shorter for sono-guided capsular distension than for fl  uoroscopically guided capsular distension.
Conclusion  Sono-guided capsular distension has comparable effects with fluoroscopically guided capsular 
distension for treatment of adhesive capsulitis of the shoulder. Sono-guided capsular distension can be substituted 
for fl  uoroscopic capsular distension and can be advantageous from the viewpoint of radiation hazard mitigation, 
time, cost-eff  ectiveness and convenience.
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INTRODUCTION
Adhesive capsulitis is described as synovial hypertro-
phy and contraction ,along with chronic infl  ammation of 
synovium with a relatively small amount of synovial fl  uid 
around the humeral head. More than 2% of the general 
population is known to have the disease; women over 50 
years of age are more likely to present with this condi-
tion.
1,2 Currently, several methods of treatment, such as 
physical therapy, pharmaceutical intervention, intra-
articular injections, and exercise therapy are in clinical 
use, although the diff  erent methods show no diff  erences 
in efficacy.
3-5 The capsular distension method has a 
therapeutic eff  ect, via rupture of the stiff  ened capsule, by 
hydropressure.
6
Under fluoroscopic guidance with contrast media in-
jection, capsular distension was performed.  After con-
firming the spinal needle’s intra-articular placement in 
the articular cavity, contrast-mixed saline was injected 
until the pressure was suffi   ciently reduced to rupture the 
capsule. Th   e rupture can be confi  rmed by the leakage of 
contrast media outside the capsule, and thisrupture usu-
ally takes place below the supscapular muscles and in the 
biceps’ tendon sheath. Th   e success rate of the procedure 
is reported at 52-82%.
5-8
Recently, ultra-sonography is more widely used in the 
diagnosis and treatment of musculoskeletal disease. Th  e 
injection method, using a blind anatomical marker, when 
previously performed, had the limitation of delivering the 
drug into precisely the expected space. Th   is method also 
leads to limitations in evaluating treatment effi   cacy. Th  e 
X-ray guided injection method has the advantage of de-
livering drugs to the targeted space but the disadvantage 
of radiological exposure for both patients and clinicians. 
Additionally, this method can only be performed in a 
well-equipped healthcare service. On the other hand, 
ultra-sonography can be easily used in an outpatient set-
ting, without the fear of radiological exposure. 
Gam et al.
5 compared the efficacy of the capsular dis-
tension method with the glucocorticoid injection to 
glucocorticoid alone. Th   eir results showed a defi  nite im-
provement in range of motion along with the actual cap-
sular distension seen in US.
5 However, few studies have 
been conducted to investigate the pros and cons of sono-
guided capsular distension, compared with fl  uoroscopi-
cally guided capsular distension in patients. This study 
aims to evaluate this very issue.
MATERIALS AND METHODS
Study subjects
Patients visiting our rehabilitation outpatient depart-
ment complainings of shoulder pain and limitation in 
motion, from January 2009 to June 2010, were initially 
selected. Th   ey were evaluated using a medical interview, 
physical exam, radiological exam, and musculoskeletal 
ultrasonography (US) in order to diagnose adhesive 
capsulitis. Among the patients diagnosed with adhesive 
capsulitis, 48 with remaining symptoms, after a 3 month-
treatment period, were enrolled in the study. All patients 
were randomly assigned into two groups: group A for 
sono-guided capsular distension and group B for fl  uoro-
scopically guided capsular distension. Patients meeting 
study inclusion criteria
9-11 were those with 1 or 2 grade 
adhesive capsulitis, with symptom durations of 3 months 
to 2 years, or those with diffi   culties in two or more of the 
following: flexion, abduction, and/or external rotation 
presenting limitation of more than 30 degrees in passive 
and active ranges of motion, compared to the normal 
side with regard to range of motion. Exclusion criteria
9-11 
encompassed the following: complete rotator cuff tear 
as seen with US, past traumatic shoulder injury requir-
ing hospitalization in the prior 6 months, severe mental 
illness, age of less than 18 years or more than 70, degen-
erative arthritis in the shoulder (detected by radiological 
studies), systemic inflammatory disease, current use of 
anti-coagulant medications, diabetes mellitus, having 
known side eff  ects with lidocaine or contrast media, and 
current infectious disease or suspected infection. 
Method
Randomization and injection frequency: After the ac-
quisition of patients’ basic characteristics, participants 
went through one of two treatment modalities. Th  e  par-
ticipants were assigned into two groups with the random 
block assignment method; patients were lined up to be 
assigned. Four patient-blocks were further subdivided 
into groups A and B, with the use of a 6 serial method: 
‘AABB, ABAB, BAAB, BABA, BBAA, ABBA’ . For every 
fourth participant, one method among 6 was randomly 
selected and assigned to that individual. Group A, under 
US guidance, was treated with 20 cc of the injection drug, Ki Deok Park, et al.
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consisting of 10 cc non-ionic contrast media Omnipaque 
300; GE Healthcare (Carrigtwohill Co., Cork, Ireland) 
mixed with 0.5% lidocaine 10 cc containing 20 mg tri-
amcinolone. Group B received fluoroscopically guided 
capsular distension with the same injection material. 
All patients received the procedure 3 times with 2 week 
intervals between treatments. Group A had additional 
radiological confi  rmation for proper intra-articular injec-
tion and evidence of capsular rupture.  
Injection method: In sono-guided capsular distension, 
the injection was performed using a posterolateral ap-
proach with Accuvix XQ
® (Medison, Seoul, Korea) and 
a 6-12 MHz probe, with patients sitting up during treat-
ment. Proper intra-articular injection was evaluated, with 
evidence of capsular distension by monitoring during the 
procedure followed by radiological exam (Fig. 1).
In fluoroscopically guided capsular distension, the 
humeral head was captured with a C-arm (KOMED, 
Kwangju, Korea) adjusted in a cephalic-to-caudal angle, 
with patients in a prone position with a pillow under-
neath the affected shoulder. After aseptic preparation, 
a 22 gauge, 3.5 inch spinal needle Spinocan
® (BRAUN, 
Melsungen, Germany) was placed superior to the ana-
tomical neck of the humerus, and a solution containing 
non-ionic contrast media (Omnipaq) was injected under 
simultaneous fl  uoroscopic imaging (Fig. 2).  
All injection methods were performed by the same 
clinician, and no further physical therapy or medication 
was added. Only shoulder self-exercise prior to the pro-
cedures was permitted. Additionally, acetaminophen, 
with no anti-inflammatory effect, or ice massages were 
permitted if patients complained of pain at the injection 
site. Acetaminophen use during the follow-up period was 
also allowed.
Evaluation of treatment efficacy: The evaluation was 
completed a total of three times, before the first injec-
tion followed by tests, and at the second and sixth weeks 
after completion of procedures. The degree of shoulder 
pain was graded with a visual numeric scale (VNS) with 
1-cm increments between 0-10 cm. Functional disability 
was assessed by the ‘Shoulder Pain and Disability Index’ 
(SPADI) proposed by Roach et al.
12 with scoring from 0 to 
80, for which 0 represents absence of disability and point 
10 represents severe disability that is in need of help for 
moving (in each of 8 categories). Range of motion in fl  ex-
ion, abduction, and external rotation was assessed both 
for passive and active movements. Flexion and abduction 
were examined in a supine position, with the main joint 
extended from the immobilized trunk using a 180-degree 
system. External rotation was examined with the shoul-
Fig. 1. Sono-guided capsular dis-
ten  sion. (A) Sono-guided capsular 
distension by the posterior lateral 
approach. (B) Before Sono-guid-
ed intra-articular injection at 
glenohumeral joint. (C) After sono-
guided injection with capsular 
distension (arrow). The needle tip 
(arrowhead). (D) Shoulder posterior-
anterior view. After steroid injection 
with capsular distension.Comparison of Sono-guided with Fluoroscopy Capsular Distension in Adhesive Capsulitis
91 www.e-arm.org
der joint abducted 90 degrees and the main joint fl  exed 
90 degrees, as measured with a goniometer. 
Comparison in patient satisfaction, effi   cacy, time con-
sumed, cost-effectiveness, and side effects: Data using 
patient questionnaires were collected by a doctor who 
had no knowledge of this study. Patients’ satisfaction lev-
els after the completion of 3 injections during a 6 week 
period were expressed as “excellent,” “good,” “fair,” and 
“poor” . Patients’ preference levels for the procedure were 
expressed in their answers to the question, “Would you 
choose to receive the same procedure again after being 
informed of side effects and the pros and cons of each 
procedure?” Th   ey could choose from:“change,” “consider 
to change,” “not change,” or “neither” . Th   e time the pro-
cedure took was calculated in seconds recorded in US 
and C-arm. 
The cost-effectiveness of each method was calculated 
with expense spent to reduce pain severity (in this study 
expressed in VNS reduction). Th  e  diff  erence between the 
two methods was calculated with the incremental cost-
eff  ective ratio (ICER), which measures the additional ex-
pense necessary for health gain of each unit as below:
13
ICER=
Average CostSONO-Average Costfl  uoroscopic
Average Eff  ectSONO-Average Eff  ectfl  uoroscopic
Cost is calculated with total cost of outpatient visits, 
and the procedure in Korean won, and effects with re-
duction by VNS scale. Complications before and after the 
procedure were also assessed. 
Statistics
We performed the student’s t-test to compare differ-
ences in age, BMI, and disease duration between the two 
groups. Normality of the sample was confirmed, with a 
Shapiro-Wilk test performed prior to the student’s t-test. 
Differences in sex, capsular rupture, and left and right 
lesions were calculated by the chi-square test. Compari-
sons of VNS, SPADI, and ROM between the two groups, 
at each period, were performed by Shapiro-Wilk test’s 
normality testing and by a two-way repeated measures 
analysis of variance ANOVA. Bonferroni’s correction was 
completed as the post-hoc test.  Procedural preferences 
and satisfactory levels were analyzed with the chi-square 
test and procedural time with the student’s t-test. Statisti-
Fig. 2. Fluoroscopically guided cap-
sular distension. (A) Fluoroscopically 
guided capsular distension by the 
posterior approach. (B) Drawing 
shows patient in prone position for 
posterior approach. (C) Shoulder 
posterior-anterior view. The needle 
tip (arrow) was inserted above 
anatomical neck of humerus (D) 
Shoulder posterior-anterior view. 
After steroid injection with capsular 
distension.Ki Deok Park, et al.
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cal analysis was processed using SAS Enterprise Guide 4.1 
(4.1.0.471); the signifi  cant p-value was set below 0.05.
RESULTS
General characteristics of patients 
Group A was composed of 23 patients (6 males and 
17 females) with a mean age of 56.04 years. The mean 
duration of disease among this group was 7.65 months. 
Group B was composed of 25 patients (8 males and 17 
females) with a mean age of 56.36 and, among this group, 
the mean disease duration was 7.44 months. Th  e  general 
characteristics of patients did not diff  er signifi  cantly be-
tween the two groups (p>0.05) (Table 1).
Change in pain severity by visual numeric scale 
VNS before the procedure was 7.07±0.76 cm in group A 
and 6.92±0.61 cm in group B. VNS measured 2 weeks af-
ter the procedure was 2.84±0.66 cm and 3.09±0.52 cm for 
groups A and B respectively. Six weeks after the procedure, 
the measurements were 2.41±0.64 cm and 2.79±0.53 cm re-
spectively, showing signifi  cant reduction in both groups. Th  e 
degree of improvement and change in duration in the two 
groups showed no statistical diff  erences (p>0.05) (Table 2). 
Change in shoulder pain and disability index
SPADI before the procedure was 64.94±9.54 and 
67.81±9.14 in groups A and B respectively. SPADI, mea-
sured 2 weeks after the final procedure, was 31.01±9.31 
and 30.02±6.55. After 6 weeks, it was 29.25±8.33 and 
27.83±6.79 for groups A and B respectively; this shows 
significant reduction in both groups. The degree of 
improvement and change over time, for both groups, 
showed no statistical diff  erences (p>0.05) (Table 3).
Change in articular range of motion in passive move-
ments
Passive range of motion, before and after the procedure, 
showed improvement for both groups and no statistical 
diff  erences between the two groups (p>0.05) (Table 4). 
Table 1. Characteristics of the Participants
A group  B group  p-value
Number of subject 23 25
Sex (female/male) 17 (73.9%)/6 (26.1%) 17 (68.0%)/8 (32.0%) 0.756
Age (years) 56.04±6.99 56.36±8.49 0.980
Duration (month) 7.65±2.33 7.44±2.14 0.660
BMI 22.39±2.82 21.81±3.35 0.716
Right/Left 12 (52.2%)/11 (47.8%)     14 (56.0%)/11 (44.0%) 1.000
Capsular distension with and 
  without rupture 
11 (47.8%)/12 (52.2%) 10 (40.0%)/15 (60%) 0.771
Values are mean±standard deviation
A group: Sono-guided capsular distension group, B group: Fluoroscopically guided capsular distension group





2 weeks after 
capsular 
distension
6 weeks after 
capsular 
distension
A group 7.07±0.76 2.84±0.66* 2.41±0.64*
B group 6.92±0.61 3.09±0.52* 2.79±0.53*
Values are mean±standard deviation
VNS: Visual numeric scale, A group: Sono-guided cap-
sular distension group, B group: Fluoroscopically guided 
capsular distension group
*p<0.05: Comparison of before vs after injection, p<0.05: 
Comparison of the A group vs B group





2 week after 
capsular 
distension
6 weeks after 
capsular 
distension
A group 64.94±9.54 31.01±9.31* 29.25±8.33*
B group 67.81±9.14 30.02±6.55* 27.83±6.79*
Values are mean±standard deviation
SPADI: Shoulder pain and Disability index, A group: 
Sono-guided capsular distension group, B group: Fluoro-
scopically guided capsular distension group
*p<0.05: Comparison with the before injectionComparison of Sono-guided with Fluoroscopy Capsular Distension in Adhesive Capsulitis
93 www.e-arm.org
Change in articular range of motion in active move-
ments
Active range of motion before and after the procedure 
showed improvement for both groups and did not show 
statistical differences between the two groups (p>0.05) 
(Table 5). 
Comparison of eﬀ  ectiveness, preference, time interval, 
cost, and side eﬀ  ects 
There were no significant differences in effectiveness 
between the two groups groups, but the preference lev-
els among group A were higher than in group B (p<0.05) 
(Table 6). Th   e time interval in group A was 119.04±12.17 
seconds, which was shorter than in group B, which was 
294.08±24.30 (p<0.05) (Table 6). Hot flush, as a side ef-
fect, was seen in 2 patients  from each group, with no sta-
tistical diff  erences between the two groups; no other side 
eff  ects were reported. 
The difference in VNS measured before the procedure 
and 6 weeks after it was Δ=4.58 and Δ=4.14 in groups A 
and B respectively (Table 7). Th   e total cost of the proce-
dure for group A was 184,284 Korean won and 283,210 
Korean won in group B. The ICER was calculated as 
224,831 won per VNS unit. Accordingly, group A’s proce-
dure cost less and showed superior outcomes. To acquire 
the treatment eff  ect of VNS 0.44 units with sono-guided 
capsular distension, the cost was an additional 98,926 
won, compared with the fl  uoroscopic-assisted method. 
DISCUSSION
The capsular distension method separates adherent 
synovium by hydropressure caused by injection of a large 
amount of fluid mixture. Since Salter had reported its 




2 weeks after capsular 
distension
6 weeks after capsular 
distension
Flexion A 126.74±10.18 148.70±8.56* 152.17±10.53*
B 123.80±9.16 144.60±8.28* 147.00±9.12*
Abduction A 99.57±10.54 132.83±9.98* 134.57±10.53*
B 100.80±13.75 129.80±6.69* 131.40±9.52*
External 
rotation
A 43.91±8.25 63.91±8.25* 66.74±6.50*
B 45.00±9.79 63.80±7.39* 64.60±5.39*
Values are mean±standard deviation
ROM: Range of Motion, A group: Sono-guided capsular distension group, B group: Fluoroscopically guided capsular 
distension group
*p<0.05: Comparison of the before vs after the injection, p<0.05: Comparison with the 2 week after the injection, 
p<0.05: Comparison of the A group vs B group




2 weeks after capsular 
distension
6 weeks after capsular 
distension
Flexion A 109.57±12.87 139.57±8.52* 143.91±9.53*
B 109.40±9.61 135.80±9.86* 139.80±10.26*
Abduction A 88.70±10.89 123.48±10.71* 127.39±8.51*
B 91.20±12.44 119.62±6.29* 126.40±11.41*
External 
rotation
A 36.09±9.04 60.22±8.05* 61.74±6.50*
B 39.20±9.32 57.40±7.23* 59.60±5.39*
Values are mean±standard deviation
ROM: Range of Motion, A group: Sono-guided capsular distension group, B group: Fluoroscopically guided capsular 
distension group
*p<0.05: Comparison of before vs after injection, p<0.05: Comparison with the 2 week after the injection, p<0.05: 
Comparison of the A group vs B groupKi Deok Park, et al.
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effectiveness in 1970, it is widely used for its low cost, 
safety, and immediate effect in ROM, in patients with 
adhesive capsulitis.
14 Rizk et al.
6 explained that capsular 
distension shares a similar mechanism with manual re-
duction under anesthesia, and patients with no improve-
ment after 3 months of conservative management should 
be treated. 
Although controversy still exists regarding whether the 
primary pathology of adhesive capsulitis is infl  ammation 
or fibrosis, it is thought that its development is limited 
to the capsule with the synovial inner layer and syno-
vial fluid.
15 Rodeo et al.
16 reported that cytokines such 
as Transforming Growth Factor-β (TGF-β) and Platelet-
Derived Growth Factor (PDGF) play critical roles in the 
inflammatory reaction and fibrosis, and the differentia-
tion process of fi  broblasts was observed. Steroid injection 
was started as treatment based on the hypothesis that the 
main pathophysiology of capsulitis is an inflammatory 
response. 
Neviaser
17 reported mild synovial infl  ammation accom-
panied by edema, vasodilation, and the deposition of 
mononuclear cells in some patients with adhesive capsu-
litis. 
As inflammation also plays an important role in the 
process of synovial fi  brosis, anti-infl  ammatory treatment 
is necessary for symptom improvement and prevention 
of further fi  brosis. Th   us, intracapsular steroid injection in 
adhesive capsulitis shows effi   cacy by reducing infl  amma-
tory response in the pathological process.
18 Additionally, 
if performed accurately, it produces faster pain control 
and ROM improvement with lower cost compared to 
conservative physiotherapy; thus, it has recently been 
widely used for outpatients.
19-21
In 1989, Fareed and Gallivan
8 showed excellent effi   cacy 
of 40 ml steroid and saline mixture injection treatment, 
without individuals needing to be admitted to the hos-
pital or needing to use arthroscope. Gam et al.
5 reported 
that patients who received capsular distension with ste-
roids, via a US-guided posterior approach, showed more 
ROM improvement and reduced use of painkillers com-
pared with patients who received intra-articular steroid 
injections. The initial mechanisms of hydraulic disten-
sion are capsular rupture and pressure-lowering by cap-
sular volume extension, then anti-inflammatory effects 
produced by administration of steroid, local anesthetics, 
and contrast media.
6 In this study, additional steroid in-
Table 6. Comparison of Eff  ectiveness, Preference, Time Interval by the Capsular Distension
Approach method p-value
Eff  ectiveness
Excellent Good Fair Poor
   A group 3 (13.0%) 15 (65.2%) 5 (21.7%) 0 (0%)
   B group 3 (12.0%) 15 (60.0%) 7 (28.0%) 0 (0%) 0.882
Preference
Not change Consider Change Neither
   A group 14 5   2 2
   B group   4 5 10 6 0.005
Time intervals (sec)
   A group 119.04±12.17
   B group 294.08±24.30 0.008
Values are mean±standard deviation
A group: Sono-guided capsular distension group, B group: Fluoroscopically guided capsular distension group
Table 7. Sono-guided Capsular Distension and Fluoro-
scopically Guided Capsular Distension Costs
A group B group
Room Utilization (won) 90,840
Procedure (won) 60,000 79,860
Drug (triamcinolone, lidocaine, 
  normal saline) (won)
3,129 3,129
Shoulder AP, LAT (won) 11,774
Technician (won) 41,301 41,301
Doctor's bill (won) 68,080 68,080
Total 184,284 283,210
A group: Sono-guided capsular distension group, B 
group: Fluoroscopically guided capsular distension groupComparison of Sono-guided with Fluoroscopy Capsular Distension in Adhesive Capsulitis
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jection with capsular distension showed improvement in 
ROM, pain, and functional ability. 
Several studies have investigated injection-targeting 
accuracy in blind trials. Yamakado
22 reported that, when 
evaluated with arthrography, targeting accuracy of reach-
ing the subacromial bursa was judged to be about 70%. 
Partington and Broome.
23 reported the targeting accuracy 
to be about 83% in reaching the subacromial bursa and 
60% in reaching the acromioclavicular joint with blind 
injection on cadavers. Erroneous decisions in diagnosis 
and treatment effi   cacy evaluation can be made with inac-
curate injection. Th   e US-guided and fl  uoroscopic meth-
ods used in this study can reduce such errors. 
Diagnostic tools for adhesive capsulitis are: arthrogra-
phy, magnetic resonance imaging (MRI), arthroscopy, 
and musculoskeletal ultra-sonography. Arthrography 
displays loss of axillary folds and biceps and reduction of 
articular volume below 10 ml. It is usually introduced as 
the examination of choice,
1,24 but has the disadvantage of 
being too invasive to be easily clinically applicable; it also 
has diagnostic limitations in patients whose articular vol-
ume has not decreased below 10 ml. Additionally, the risk 
of radiological exposure to both patients and examiner is 
high. Additional radiological studies may be necessary in 
order to rule out other rotator cuff   diseases.
Holsebeeck and Introcaso.
25 reported sonographic fi  nd-
ings of adhesive capsulitis as continuous limitations of 
subacromial suprasinatus sliding movements in shoulder 
abduction and the lateral view of supraspinatus. Sonog-
raphy enables diagnosis during direct monitoring of pa-
tients’ movements, without risk of radiological exposure. 
Furthermore, sonographic measurement of the coraco-
humeral ligament’s thickness in the girdle band is useful 
in diagnosing adhesive capsulitis.
26
In performing sonographic capsular distension, it was 
diffi   cult to access the full view of the capsule, as in fl  uo-
roscopy. To compensate for this defect, distension was 
confi  rmed during drug injection, and an additional fl  uo-
roscopic exam using contrast media was performed in 
order to check the shoulder capsule following drug injec-
tion. 
Effi   cacy for the two groups showed no statistical diff  er-
ences but with regard to preference, 24 patients (50%) of 
the total study population chose sonographic capsular 
distension and had higher preferences for it than fl  uoro-
scopic distension, which was chosen by only 6 patients 
(12.5%). 
The main reason patients preferred sonographic dis-
tension was lack of radiological exposure. X-rays during 
fl  uoroscopic distension mean a type of ionizing radiation 
and have potent biological eff  ects. Even a small amount 
can cause molecular damage and be carcinogenic in the 
future.
27 The International Commission of Radiological 
Protection estimates the annual maximal permissible 
dose on several organs and recommends that an exam-
iner or patient not be exposed to more than 10% of the 
permissible dose.
28 Th   e usual incidental skin dose during 
a one-minute fluoroscopic interventional procedure is 
1-10 R (Roentgen) with a 2R per minute ray, equal to a 
radiological exposure of 130 times a chest radiograph, as 
an incidental skin dose of a typical chest X-ray is 15 mR 
(milliroentgen).
25 Th   us, a procedure without risk of radio-
logical exposure is preferred. 
A total of 8 patients, 2 in group A and 6 in group B, re-
fused both procedures because of pain during involved in 
them. As pain can reduce patients’ compliance to proce-
dures, further studies ought to be performed in this fi  eld. 
Th   e limitations of this study were the small number of 
patients and the short (6-week) follow-up period. Enroll-
ment criteria included patients of 1 and 2 grade adhesive 
capsulitis, with symptom duration lasting between 3 
months and 2 years, but grade 3 patients could have been 
included for period overlap. Additionally, the cost was 
calculated for four diff  erent hospitals, for reliable results 
in evaluating cost-eff  ectiveness. However, the part of the 
cost not covered by insurance differed among hospitals 
and was a limitation in analysis of cost-effectiveness. 
Even though individuals were examined by an expert 
with 5 years of experience in musculoskeletal ultrasonog-
raphy and C-arm, the procedure time diff  erences accord-
ing to inter-examiners’ performance abilities remains a 
limitation.
A larger number of subjects, with a longer follow-up 
period comparing multiple methods of capsular disten-
sion, are needed in order to fully assess effi   cacy and cost-
eff  ectiveness in the future. 
CONCLUSION
In the comparison of sono-guided capsular distension 
with fl  uoroscopically guided capsular distension in adhe-
sive capsulitis, results showed no statistical diff  erences in Ki Deok Park, et al.
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ROM improvement and pain control. However, the sono-
guided capsular distension method is preferred among 
patients due to lack of radiological exposure, lower cost, 
and faster procedure time. 
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